Immune biomarkers of anti-EGFR monoclonal antibody therapy

The tumor antigen (TA)-targeted monoclonal antibodies (mAb) cetuximab and panitumumab target the human epidermal growth factor receptor and have been integrated into treatment regimens for advanced squamous cell carcinoma of the head and neck (SCCHN). The therapeutic efficacy of these mAbs has been...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Oncol
Main Authors: Trivedi, S., Concha-Benavente, F., Srivastava, R. M., Jie, H. B., Gibson, S. P., Schmitt, N. C., Ferris, R. L.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2015
Teme:
Reviews
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269339/
https://ncbi.nlm.nih.gov/pubmed/24997207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdu156
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki